Topics
November/December 2016 | Special Focus: The Year In Review
Recapping the Past 12 Months
the staff of Retina Today
November/December 2015 | Special Focus: The Year In Review
In the Rearview: Highlights of Happenings From 2015
A brief look at significant events, innovative products, and other notable headlines from the past year.
From the staff of Retina Today
November 17, 2026
MacuMira Receives CE Mark Certification for Retinal Microcurrent Stimulation Device to Treat Dry AMD
November 16, 2026
Johnson & Johnson to Acquire Ollin Biosciences for $2.2 Billion, Advancing Retinal Disease Pipeline
RetinaLyze System Receives EU MDR Class 2a Certification for Retinal Screening Software
November 11, 2026
AAO, AOA Respond to FDA GLP-1 Drug Labeling Changes, Highlight NAION Risk and Eye Care Recommendations
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Supported by Zeiss
Free Print Subscription
Email Newsletter
Conference Calendar